Literature DB >> 2440311

Angiotensin decreases cyclic GMP accumulation produced by atrial natriuretic factor.

J B Smith, T M Lincoln.   

Abstract

Atrial natriuretic factor (ANF) produced rapid increases in cyclic GMP (cGMP) in cultured aortic smooth muscle cells. Angiotensin II (ANG II) markedly decreased the accumulation of cGMP that was evoked by ANF. Arginine vasopressin and ATP, which evoke transient increases in free Ca2+ similarly to ANG II, also inhibited cGMP accumulation. The effect of the calcium mobilizing neurohormones was mimicked by the divalent cation ionophore, A23187. The cyclic nucleotide phosphodiesterase inhibitor, 3-isobutyl-1-methylxanthine, prevented ANG II from inhibiting ANF-evoked cGMP accumulation. ANG II also inhibited cGMP accumulation induced by nitroprusside, a compound that activates cytosolic guanylate cyclase. These findings support the hypothesis that ANG II decreases cGMP accumulation by stimulating cGMP hydrolysis, apparently via a Ca2+-activated cGMP phosphodiesterase.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2440311     DOI: 10.1152/ajpcell.1987.253.1.C147

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

1.  Effect of cyclic guanosine monophosphate on hypoxic and angiotensin-II-induced pulmonary vasoconstriction.

Authors:  K Fujimoto; A Sakai; S Yoshikawa; S Shinozaki; Y Matsuzawa; K Kubo; T Kobayashi; G Ueda; M Sekiguchi; N F Voelkel
Journal:  Lung       Date:  1990       Impact factor: 2.584

2.  Interaction of atriopeptin III and vasopressin on calcium kinetics and contraction of aortic smooth muscle cells.

Authors:  H Meyer-Lehnert; C Caramelo; P Tsai; R W Schrier
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

3.  Potentiation of atrial natriuretic peptide-stimulated cyclic guanosine monophosphate formation by glucocorticoids in cultured rat renal cells.

Authors:  K Kanda; K Ogawa; N Miyamoto; T Hatano; H Seo; N Matsui
Journal:  Br J Pharmacol       Date:  1989-04       Impact factor: 8.739

4.  Guanylyl cyclase-A phosphorylation decreases cardiac hypertrophy and improves systolic function in male, but not female, mice.

Authors:  Brandon M Wagner; Jerid W Robinson; Chastity L Healy; Madeline Gauthier; Deborah M Dickey; Siu-Pok Yee; John W Osborn; Timothy D O'Connell; Lincoln R Potter
Journal:  FASEB J       Date:  2022-01       Impact factor: 5.191

5.  Angiotensin inhibition potentiates the renal responses to neutral endopeptidase inhibition in dogs with congestive heart failure.

Authors:  K B Margulies; M A Perrella; L J McKinley; J C Burnett
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

6.  Phosphorylation of atrial natriuretic factor R1 receptor by serine/threonine protein kinases: evidences for receptor regulation.

Authors:  L Larose; J J Rondeau; H Ong; A De Léan
Journal:  Mol Cell Biochem       Date:  1992-10-07       Impact factor: 3.396

7.  Na+/K+/Cl- cotransport in cultured vascular smooth muscle cells: stimulation by angiotensin II and calcium ionophores, inhibition by cyclic AMP and calmodulin antagonists.

Authors:  J B Smith; L Smith
Journal:  J Membr Biol       Date:  1987       Impact factor: 1.843

Review 8.  Natriuretic peptides in the pathophysiology of congestive heart failure.

Authors:  H H Chen; J C Burnett
Journal:  Curr Cardiol Rep       Date:  2000-05       Impact factor: 3.955

Review 9.  Aortocaval fistula in rat: a unique model of volume-overload congestive heart failure and cardiac hypertrophy.

Authors:  Zaid Abassi; Ilia Goltsman; Tony Karram; Joseph Winaver; Aaron Hoffman
Journal:  J Biomed Biotechnol       Date:  2011-01-11

10.  Endothelin (ET)-3 stimulates cyclic guanosine 3',5'-monophosphate production via ETB receptor by producing nitric oxide in isolated rat glomerulus, and in cultured rat mesangial cells.

Authors:  A Owada; K Tomita; Y Terada; H Sakamoto; H Nonoguchi; F Marumo
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.